Mathematical model of cancer growth controled by metronomic chemotherapies
ESAIM: Proc., 41 (2013) 77-94
Published online: 2013-12-09
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial
Hongnan Mo, Yongpei Yu, Xiaoying Sun, Hewei Ge, Lanlan Yu, Xiuwen Guan, Jingtong Zhai, Aihua Zhu, Yuhan Wei, Jinjing Wang, Xiaoyan Yan, Haili Qian, Binghe Xu and Fei MaNature Medicine 30 (9) 2528 (2024)
https://doi.org/10.1038/s41591-024-03088-2
Modeling for the body defense mechanisms in stage I melanoma patient and sensitivity analysis by using Partial Rank Correlation Coefficient (PRCC) method
elnaz kalhor, amin noori, Jalil Tavakol Afshari and sara Saboori RadJournal of Control 15 (2) 159 (2021)
https://doi.org/10.52547/joc.15.2.159
Darwinian Approaches for Cancer Treatment: Benefits of Mathematical Modeling
Sophia Belkhir, Frederic Thomas and Benjamin RocheCancers 13 (17) 4448 (2021)
https://doi.org/10.3390/cancers13174448
A size and space structured model describing interactions of tumor cells with immune cells reveals cancer persistent equilibrium states in tumorigenesis
Kevin Atsou, Fabienne Anjuère, Véronique M. Braud and Thierry GoudonJournal of Theoretical Biology 490 110163 (2020)
https://doi.org/10.1016/j.jtbi.2020.110163
Pharmacokinetic/pharmacodynamic modeling of combination-chemotherapy for lung cancer
Louis T. Curtis, Victor H. van Berkel and Hermann B. FrieboesJournal of Theoretical Biology 448 38 (2018)
https://doi.org/10.1016/j.jtbi.2018.03.035
Optimization of an in vitro chemotherapy to avoid resistant tumours
Cécile CarrèreJournal of Theoretical Biology 413 24 (2017)
https://doi.org/10.1016/j.jtbi.2016.11.009
Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial
Emilia Montagna, Antonella Palazzo, Patrick Maisonneuve, et al.Cancer Letters 400 276 (2017)
https://doi.org/10.1016/j.canlet.2017.01.027
Evaluating the efficacies of Maximum Tolerated Dose and metronomic chemotherapies: A mathematical approach
Rafael T. Guiraldello, Marcelo L. Martins and Paulo F.A. ManceraPhysica A: Statistical Mechanics and its Applications 456 145 (2016)
https://doi.org/10.1016/j.physa.2016.03.019
An in vitro assessment of liposomal topotecan simulating metronomic chemotherapy in combination with radiation in tumor-endothelial spheroids
Amar Jyoti, Kyle D. Fugit, Pallavi Sethi, et al.Scientific Reports 5 (1) (2015)
https://doi.org/10.1038/srep15236
Analysis and numerical solution of stochastic phase‐field models of tumor growth
Ernesto A. B. F. Lima, Regina C. Almeida and J. Tinsley OdenNumerical Methods for Partial Differential Equations 31 (2) 552 (2015)
https://doi.org/10.1002/num.21934
Metronomics: towards personalized chemotherapy?
Nicolas André, Manon Carré and Eddy PasquierNature Reviews Clinical Oncology 11 (7) 413 (2014)
https://doi.org/10.1038/nrclinonc.2014.89